Fosun Pharmaceutical Raises $510 Million in IPO

HONG KONG—Shanghai Fosun Pharmaceutical (Group) Co. raised US$510 million in an initial public offering in Hong Kong, after pricing the deal at the low end of the indicative price range, people with direct knowledge of the matter said Tuesday.

Share